pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

COMPANY OVERVIEW

QUE Oncology is a clinical stage company developing drugs for large unmet medical needs. The company’s lead drug program, Q-122, is focussed on the treatment of hot flashes in breast cancer survivors undergoing endocrine therapy.

LOCATION

THERAPEUTIC AREAS

  • Women's Health

    • WEBSITE

    https://www.queoncology.com

    CAREER WEBSITE

    None

    SOCIAL MEDIA

    INVESTORS

    medical-research-commercialization-fund uniseed

    PRESS RELEASES


    Nov 10, 2022

    QUE Oncology's non-hormonal therapy reduces hot flushes and night sweats in women with breast cancer, published in The Lancet


    Jul 29, 2019

    QUE Oncology Appoints Dr. Julie Cherrington and Elizabeth Cermak to Board of Directors


    Apr 2, 2019

    QUE Oncology Launches Phase II Trials in the United States


    Nov 3, 2014

    QUE Oncology, Inc. Announces Positive Phase 1 Results with Q-122


    For More Press Releases
    Google Analytics Alternative